Human embryonic stem cell-derived hematopoietic cells are capable of engrafting primary as well as secondary fetal sheep recipients

A. Daisy Narayan, Jessica L. Chase, Rachel L. Lewis, Xinghui Tian, Dan S. Kaufman, James A. Thomson, Esmail D. Zanjani

Research output: Contribution to journalArticlepeer-review

108 Scopus citations

Abstract

The human/sheep xenograft model has proven valuable in assessing the in vivo hematopoietic activity of stem cells from a variety of fetal and postnatal human sources. CD34+/lineage- or CD34+/ CD38- cells isolated from human embryonic stem cells (hESCs) differentiated on S17 feeder layer were transplanted by intraperitoneal injections into fetal sheep. Chimerism in primary transplants was established with polymerase chain reaction (PCR) and flow cytometry of bone marrow and peripheral blood samples. Whole bone marrow cells harvested from a primary recipient were transplanted into a secondary recipient. Chimerism was established as described before. This animal was stimulated with human GM-CSF, and an increase in human hematopoietic activity was noted by flow cytometry. Bone marrow aspirations cultured in methylcellulose generated colonies identified by PCR to be of human origin. We therefore conclude that hESCs are capable of generating hematopoietic cells that engraft primary recipients. These cells also fulfill the criteria for long-term engrafting hematopoietic stem cells as demonstrated by engraftment and differentiation in the secondary recipient.

Original languageEnglish (US)
Pages (from-to)2180-2183
Number of pages4
JournalBlood
Volume107
Issue number5
DOIs
StatePublished - Mar 1 2006

Fingerprint

Dive into the research topics of 'Human embryonic stem cell-derived hematopoietic cells are capable of engrafting primary as well as secondary fetal sheep recipients'. Together they form a unique fingerprint.

Cite this